Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes.
about
"Stormy waters ahead": global emergence of carbapenemasesClinical management of infections caused by multidrug-resistant EnterobacteriaceaeElucidation of quantitative structural diversity of remarkable rearrangement regions, shufflons, in IncI2 plasmidsNew β-lactamase inhibitors: a therapeutic renaissance in an MDR world.The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosaDrugs of last resort? The use of polymyxins and tigecycline at US Veterans Affairs medical centers, 2005-2010.Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study.The use of intravenous colistin among children in the United States: results from a multicenter, case seriesCarbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital.Global spread of Carbapenemase-producing EnterobacteriaceaeDetection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales.Combination therapy for treatment of infections with gram-negative bacteria.Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.Intravenous Colistin Use for Multidrug-Resistant Gram-Negative Infections in Pediatric PatientsCarbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensionsKPC-producer gram negative bacteria among burned infants in Motahari Hospital, Tehran: first report from Iran.Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract.Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program.Coproduction of 16S rRNA methyltransferase RmtD or RmtG with KPC-2 and CTX-M group extended-spectrum β-lactamases in Klebsiella pneumoniae.Infections caused by extended-spectrum beta-lactamases producing Enterobacteriaceae: clinical and economic impact in patients hospitalized in 2 teaching hospitals in Dakar, SenegalThe role of doxycycline in the therapy of multidrug-resistant E. coli - an in vitro study.Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.OXA-48-like carbapenemases: the phantom menace.Carbapenemase-producing Enterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back?Proliferation and significance of clinically relevant β-lactamases.Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.The prevention and management of infections due to multidrug resistant organisms in haematology patientsDeaths attributable to carbapenem-resistant Enterobacteriaceae infections.Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.Horizontal Dissemination of Antimicrobial Resistance Determinants in Multiple Salmonella Serotypes following Isolation from the Commercial Swine Operation Environment after Manure Application.Recent Research Examining Links Among Klebsiella pneumoniae from Food, Food Animals, and Human Extraintestinal Infections.Whole-genome sequencing of Klebsiella pneumoniae MDR strain isolated in a Syrian refugee.Challenges and opportunities for whole-genome sequencing-based surveillance of antibiotic resistance.Co-production of NDM-1 and OXA-232 by ST16 Klebsiella pneumoniae, Italy, 2016.Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients.Comprehensive resistome analysis reveals the prevalence of NDM and MCR-1 in Chinese poultry production.Carbapenem-Resistant Klebsiella pneumoniae: Results of a Laboratory Surveillance Program in an Italian General Hospital (August 2014-January 2015) : Surveillance of Carbapenem-resistant Klebsiella pneumoniae.In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.Comparative Evaluation of the in-vitro Activity of Six β-lactam/β-lactamase Inhibitor Combinations against Gram Negative Bacilli.
P2860
Q21131125-308C96D1-9B82-4DB2-BB2A-AEF72732CFD0Q28246841-65C90488-ECC5-4559-A4F9-4204736A5327Q30850486-179CF255-5E4E-4801-80BF-28C34275DB37Q33622976-C836F267-716B-4FC4-AFDE-4B7D25AD4D41Q33856134-CA46FA7C-2832-47FB-B489-9502857388E1Q34277350-27406538-13A5-459F-AD11-0FBDF3AAC70CQ35214110-B5A597AD-C32C-458D-BE1E-460BD4F99F00Q35592264-A3FF1DC4-EF9C-4924-B594-E36D0EAC4DB1Q35763406-6FD20D07-E76E-41B8-A865-21799E28EFBAQ35847641-43A1526C-D85F-4903-8299-F4E58BEF82A0Q35992938-F6AD4B0A-F70D-4A67-A49E-00DDE317AD24Q36156077-95F2ACE5-7AD2-4BB3-A296-5B2363439795Q36212092-B7B62174-6BDC-4666-95EB-136687FC0C92Q36229076-A47548DA-D288-4234-95FF-CA0EB6BB67A8Q36361921-E0356C4F-3903-4531-85C8-05A8E7114FD8Q36422961-2A5FFFBE-4142-4DD0-A11C-BD4185B05C52Q36506349-E36E04FD-CB86-444D-B0B1-6AA9BDD5CABAQ36644582-B8AC0D8D-3998-4B7B-8BF0-31C120F1B778Q36785872-BBF86224-F18F-40C4-BBDE-4BD165DB5B6EQ36810438-715B93DA-956D-4ED1-947A-01D1EC2FF129Q37184911-1E0242E7-94C7-447F-803A-3A0A8BCBFF3AQ37358700-7A37D8DF-F344-47E9-83EC-5BAEA4112475Q37957839-1A8CCB7D-7CD0-4E73-91F3-A2CDDA04291BQ38002399-0A15652D-9390-41C3-A464-172F23135A12Q38068483-931DFFED-CEA1-42C8-8513-59E30C9EFB57Q38076454-3C57054C-4B3E-466B-AD5D-668BB6AA8825Q38147851-1C92E4D5-4365-4A3D-BA37-92AA360D6484Q38171538-D4BAE283-DCFC-4F44-8B76-D3DB7C43C3EDQ38222776-6AB9B68C-16D8-420A-A579-84784F83853DQ38306504-DBC04B7C-4EA8-43FC-9C3D-8A65BD53E0DAQ38627786-0BAE7300-B51D-4AAE-B536-460BE1C5018BQ38792133-49F44F90-C82A-469D-962C-A6AC4D06B6E0Q38875811-69DB4D51-481B-49AD-BCC2-7973A2319E6EQ38992444-B314619D-18E6-4212-8213-A237F913054CQ40056360-9101F9D0-9AEA-4770-8DE9-AACF334F09FCQ40087078-B8B0E0B0-1948-4C06-86B1-02D3A09EBB9AQ40343699-740BF40B-C0A5-4097-B179-0B626A527054Q40818288-AAABC998-E1B2-49DB-BAD2-919E1AC0A637Q41077618-8EAD66FC-43BF-471B-9B5A-997F3743F760Q41437396-072F30B2-B768-4B45-8522-3A4FB124278F
P2860
Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic options for infect ...... arbapenem-hydrolyzing enzymes.
@en
Therapeutic options for infect ...... arbapenem-hydrolyzing enzymes.
@nl
type
label
Therapeutic options for infect ...... arbapenem-hydrolyzing enzymes.
@en
Therapeutic options for infect ...... arbapenem-hydrolyzing enzymes.
@nl
prefLabel
Therapeutic options for infect ...... arbapenem-hydrolyzing enzymes.
@en
Therapeutic options for infect ...... arbapenem-hydrolyzing enzymes.
@nl
P2860
P356
P1433
P1476
Therapeutic options for infect ...... arbapenem-hydrolyzing enzymes.
@en
P2093
Drosos E Karageorgopoulos
P2860
P304
P356
10.2217/FMB.11.49
P577
2011-06-01T00:00:00Z